CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques (Q45420331)

14 December 2017

CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques (English)

1 reference

14 December 2017

Teleshova N

1

1 reference

14 December 2017

Kenney J

2

1 reference

14 December 2017

Williams V

3

1 reference

14 December 2017

Van Nest G

4

1 reference

14 December 2017

Marshall J

5

1 reference

14 December 2017

Lifson JD

6

1 reference

14 December 2017

Sivin I

7

1 reference

14 December 2017

Dufour J

8

1 reference

14 December 2017

Bohm R

9

1 reference

14 December 2017

Gettie A

10

1 reference

14 December 2017

Pope M

11

1 reference

14 December 2017

1 February 2006

1 reference

Journal of Leukocyte Biology

14 December 2017

1 reference

14 December 2017

79

1 reference

14 December 2017

2

1 reference

14 December 2017

257-267

1 reference

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

14 December 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Progress on new vaccine strategies for the immunotherapy and prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

HIV and SIV CTL escape: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Progress toward an HIV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

B cell antigen receptor signaling 101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Divide and conquer: the importance of cell division in regulating B-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

B-cell immunodeficiency in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Use of CpG oligodeoxynucleotides as immune adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Toll-like receptor 9, CpG DNA and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Differential signaling by CpG DNA in DCs and B cells: not just TLR9

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Dendritic cells control B cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

The simian immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Activation of macaque T cells and B cells with agonistic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Superior activity of the type C class of ISS in vitro and in vivo across multiple species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Modulation of dendritic cell maturation and function by B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Immunodeficiency virus exploitation of dendritic cells in the early steps of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Virus infection of dendritic cells: portal for host invasion and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Interleukin 6 and its receptor: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

In vivo expression of interleukin-8, and regulated on activation, normal, T-cell expressed, and secreted, by human germinal centre B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Identifiers

DOI

10.1189/JLB.0205084

1 reference

14 December 2017

1 reference